Related Experiment Video
Updated: Jul 16, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Florid histiocytic hemophagocytosis following therapy with long acting G-CSF (pegfilgrastim)
Lewis Glasser1, Mark Legolvan, Harold M Horwitz
1Department of Pathology and Laboratory Medicine, Brown Medical School, Rhode Island Hospital, Providence, Rhode Island 02903, USA. LGlasser@Lifespan.org
We describe a case of histiocytic hemophagocytosis and increase in blasts in the bone marrow after administration of long acting G-CSF (pegfilgrastim) in a 71-year-old man with underlying myelodysplasia. Pegfilgrastim was discontinued, with resolution of the hemophagocytosis and marked decrease in blasts from 30 to 5%. We postulate that pegfilgrastim provided a continuous stimulation of the monocyte/macrophage system, resulting in histiocytic hemophagocytosis. We recommend caution in defining indications for the use of long acting preparations of G-CSF.
We describe a case of histiocytic hemophagocytosis and increase in blasts in the bone marrow after administration of long acting G-CSF (pegfilgrastim) in a 71-year-old man with underlying myelodysplasia. Pegfilgrastim was discontinued, with resolution of the hemophagocytosis and marked decrease in blasts from 30 to 5%. We postulate that pegfilgrastim provided a continuous stimulation of the monocyte/macrophage system, resulting in histiocytic hemophagocytosis. We recommend caution in defining indications for the use of long acting preparations of G-CSF.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Cryptococcal Meningitis
Differentiation of Common Myeloid Progenitor Cells